2023-08-03 16:56:38 ET
- TransMedics Group press release ( NASDAQ: TMDX ): Q2 GAAP EPS of -$0.03 beats by $0.11 .
- Revenue of $52.47M (+155.7% Y/Y) beats by $10.05M .
- Outlook: TransMedics is updating its full year 2023 revenue guidance to be in the range of $180 million to $190 million, which represents 93% to 103% growth compared to the company's prior year revenue. TransMedics' prior 2023 revenue guidance was $160 million to $170 million.
- Shares +1.11% .
For further details see:
TransMedics Group GAAP EPS of -$0.03 beats by $0.11, revenue of $52.47M beats by $10.05M